Interactive Transcript
0:01
So here is a pediatric patient with anterior shin pain.
0:08
We have a fat-suppressed fluid sequence...
0:12
a fat-suppressed fluid sensitive sequence on the left,
0:15
similarly in the axial plane and a coronal T1 sequence here.
0:20
When I see an anterior tibia lesion that looks like this,
0:23
that has sort of scalloped margins that's located predominantly in the cortex
0:29
and in the surrounding marrow, centered in the tibia,
0:32
there are two things I consider.
0:34
I consider adamantinoma,
0:36
which is a malignant diagnosis, and osteofibrous dysplasia.
0:41
What this is.
0:42
Adamantinoma, since it is malignant,
0:44
tends to be a lot more aggressive in its appearance.
0:46
So you'd see more soft tissue edema, more bony destruction.
0:50
This looks like it's just sort of growing in the bone, having scalloped margins.
0:54
It's not really doing any kind of infiltration.
0:58
Right? Look at the margins here.
0:59
You can see the scalloped very, very well.
1:02
There's some expansion, but absolutely no edema in the surrounding soft tissues.
1:07
No edema over here.
1:08
Doesn't have any relationship to neurovascular bundle.
1:12
It looks like a benign lesion.
1:14
When I see something like this, I usually recommend a plain radiograph
1:18
because it has a very characteristic appearance.
1:20
I don't have one to share with you on this case because they didn't get one.
1:23
I felt pretty confident that this was
1:25
the diagnosis of osteofibrous dysplasia, and that's what this ended up being.
1:29
But look at the margins. That's the key thing.
1:32
Looking at the margins...
1:34
Don't worry about what's happening
1:35
in the marrow, because it can elicit a little bit of edema in the marrow,
1:38
but predominantly at the cortex and in the soft tissues,
1:41
it should be very, very clean.
1:43
There should be no periosteal reaction also.
1:45
And the scalloped, location.
1:47
Two things,
1:49
adamantinoma, osteofibrous dysplasia.
1:52
This is osteofibrous dysplasia.
© 2024 MRI Online. All Rights Reserved.